Secteur Xenon Pharmaceuticals Inc.

Actions

XENE

CA98420N1050

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 20:55:23 31/07/2026 Varia. 5j. Varia. 1 janv.
63,16 USD -1,61% Graphique intraday de Xenon Pharmaceuticals Inc. -3,39% +41,01%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-1,61%-3,39%+4,81%+12,60%+41,01%+106,94%+71,18%+259,50%+749,46% 6,2 Md
+2,35%+0,77%+3,15%+17,23%+41,69%+29,92%+85,38%-14,38% - 55,23 Md
-0,21%-7,38%-6,12%+8,85%+3,93%+25,34%+63,02%+185,44%+5 966,78% 53,75 Md
-2,38%+1,68%-3,29%-6,88%-4,59%-15,51%-16,57%-73,30% - 23,48 Md
-3,16%-8,19%-8,26%-26,34%-43,60%-8,50%+344,39%+306,82%+744,79% 22 Md
+2,49%-1,27%+11,97%+17,25%+23,22%+15,99%-10,53%-67,31% - 19,78 Md
+0,79%-1,06%+3,25%+9,71%-8,31%+29,29%-33,32%-34,77%+52,59% 17,44 Md
+0,58%-7,23%+10,91%+3,07%+23,36%+24,50%+519,07% - - 14,66 Md
-4,88%-3,78%-1,27%+21,97%+21,55%+47,09%+170,29%+209,20%+474,70% 14,07 Md
+3,41%-7,83%-12,25%+77,89%+150,18%+161,76%+284,91%+1 349,84%+609,16% 13,02 Md
-5,78%-15,01%-10,03%-9,92%-20,53%+52,98%+125,42%+426,36%+6 616,69% 11,37 Md
-2,13%-0,30%+6,09%+14,08%+28,54%+440,13%+147,22%+25,48%+1 356,31% 12,3 Md
+0,80%-8,61%+6,70%-30,82%-16,86%-38,51%+118,74%+82,25% - 10,95 Md
-2,73%-3,29%-8,42%+23,25%+22,88%+107,44%+134,12%+171,39%+579,55% 10,92 Md
-1,64%-3,00%-7,86%-17,78%-24,24%-49,75%+530,95%+70,97%+99,25% 10,72 Md
+0,09%+0,02%+116,51%+114,62%+79,90%+192,92%+340,76%+378,00% - 8,82 Md
-2,86%-3,65%+10,70%+41,75%+200,38%+479,88%+596,55%-36,00%-17,48% 8,93 Md
+2,96%-6,36%+10,03%-18,74%+13,54%+26,35%+72,47%-17,63% - 7,93 Md
-3,77%-10,73%+1,83%+20,09%+6,77%+13,22%+297,28%+312,16% - 7,69 Md
-2,90%-0,41%-2,93%-4,38%+17,98%+60,34%+13,26%+142,15% - 8,08 Md
Moyenne -1,04%-2,93%+6,28%+13,38%+27,84%+85,09%+192,73%+193,48%+1 566,53% 16,87 Md
Moyenne pondérée par Capi. -0,47%-1,19%+2,79%+11,22%+21,75%+59,58%+153,10%+153,42%+2 525,71%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action XENE
  4. Secteur Xenon Pharmaceuticals Inc.